CI vs PRAX · P/E 2.4, rev $274.90B vs rev $8.6M
Cigna Corp (CI) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the CI and PRAX stock pages for the full models.
Not investment advice.